“…Since 1998, of 20 published cases of homozygous protein C deficiency presenting with neonatal purpura fulminans worldwide, 2,6,7,9,[11][12][13][14][15][16][17][18] most have had a poor clinical outcome; 75% have complete blindness (n = 15), 33% have severe neurological impairment (n = 6), and 10% have died within the first few days of life (n = 2). Other major morbidities such as renal failure (n = 2), epilepsy (n = 1), and impaired growth and development (n = 4) have also been reported, with only 3 patients having escaped any major morbidity, because of very early and continuous treatment with protein C concentrate.…”